COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS‐CoV‐2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care NetworkCharlotte Lanièce Delaunay, Nuno Verdasca, Susana Monge et al.|Influenza and Other Respiratory Viruses|2025Cited by 10